Jack Khattar
Fondatore presso SUPERNUS PHARMACEUTICALS, INC.
Patrimonio netto: 53 M $ in data 31/05/2024
Profilo
Jack A.
Khattar is the founder of Supernus Pharmaceuticals, Inc. (founded in 2005) where he holds the title of President, CEO, Secretary & Director.
He is currently the Chairman at Cognition Therapeutics, Inc. (since 2020), scPharmaceuticals, Inc. (since 2016), and Adamas Pharmaceuticals LLC (since 2021), where he also holds the titles of President, Secretary, Treasurer & Director.
He is also a Director at Navitor Pharmaceuticals, Inc. and an Advisor at New Rhein Healthcare Investors.
In his former positions, Mr. Khattar served as the President, Chief Executive Officer & Director at Shire Laboratories, Inc. (1999-2005) and as the Chairman and VP Business Development at CIMA Labs, Inc. (1995-1999).
He was also a Director at Prevacus, Inc. (2015-2020) and Rockville Economic Development, Inc. (2003-2013).
Additionally, he held positions at Merck & Co., Inc., Novartis Corp., Kodak Ltd., and was a Member of the Licensing Executives Society.
Mr. Khattar received his undergraduate degree from the American University of Beirut and an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/04/2024 | 1 937 667 ( 3.52% ) | 53 M $ | 31/05/2024 | |
SCPHARMACEUTICALS, INC.
0.01% | 16/04/2024 | 5 000 ( 0.01% ) | 19 550 $ | 31/05/2024 |
| 15/04/2024 | 6 000 ( 0.01% ) | 11 700 $ | 31/05/2024 |
Posizioni attive di Jack Khattar
| Società | Posizione | Inizio |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Fondatore | 30/03/2005 |
| SCPHARMACEUTICALS INC. | Presidente | 01/11/2017 |
| COGNITION THERAPEUTICS, INC. | Presidente | 20/04/2021 |
| ADAMAS PHARMACEUTICALS, INC. | Presidente | 24/11/2021 |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Consulente / Consigliere | - |
Precedenti posizioni note di Jack Khattar
| Società | Posizione | Fine |
|---|---|---|
Prevacus, Inc.
 Prevacus, Inc. BiotechnologyHealth Technology Prevacus, Inc. is engaged in biotechnology services. The company was founded by Jacob Vanlandingham and is headquartered in Tallahassee, FL. | Direttore/Membro del Consiglio | 01/01/2020 |
Rockville Economic Development, Inc.
 Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Rockville Economic Development, Inc. is a public-private partnership that aims to strengthen and broaden the economy of Rockville, MD through entrepreneurship, attraction, expansion, retention, and incentive programs. The non-profit company provides useful research and statistics about demographics, workforce, and business in Rockville to help businesses succeed. Rockville is an ideal place for business success, particularly in key industries such as biohealth and tech. The company also creates partnerships throughout the community to expand a network of services and offer critical resources for small businesses. | Direttore/Membro del Consiglio | 01/01/2013 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Amministratore Delegato | 01/01/2005 |
| ░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Jack Khattar
| American University of Beirut | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| COGNITION THERAPEUTICS, INC. | Health Technology |
| SCPHARMACEUTICALS INC. | Health Technology |
| Aziende private | 10 |
|---|---|
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Prevacus, Inc.
Prevacus, Inc. BiotechnologyHealth Technology Prevacus, Inc. is engaged in biotechnology services. The company was founded by Jacob Vanlandingham and is headquartered in Tallahassee, FL. | Health Technology |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Health Technology |
Kodak Ltd.
 Kodak Ltd. Electronics/AppliancesConsumer Durables Kodak Ltd. develops photographic, synthetic chemicals and photographic films. The company products include digital cameras, software, printers, accessories and picture CDs. Kodak is headquartered in Hemel Hempstead, UK. | Consumer Durables |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Commercial Services |
| Licensing Executives Society | |
Rockville Economic Development, Inc.
Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Rockville Economic Development, Inc. is a public-private partnership that aims to strengthen and broaden the economy of Rockville, MD through entrepreneurship, attraction, expansion, retention, and incentive programs. The non-profit company provides useful research and statistics about demographics, workforce, and business in Rockville to help businesses succeed. Rockville is an ideal place for business success, particularly in key industries such as biohealth and tech. The company also creates partnerships throughout the community to expand a network of services and offer critical resources for small businesses. | Commercial Services |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
- Borsa valori
- Insiders
- Jack Khattar
